Biochemical Engineering
Johnson & Johnson COVID-19 Vaccine to be Manufactured in Africa
8th March 2022
Johnson & Johnson announced on March 8, 2022 that a landmark agreement between Janssen Pharmaceuticals and manufacturer Aspen SA Operations, based in South Africa, will enable the first COVID-19 vaccine to be manufactured by an African company for people living in Africa. Source: Biopharm International 8/3/2022
Back to group news